Will the new 15-minute COVID-19 test solve US testing problems?
T2 Bioystems Spikes 19% On FDA Nod For Covid-19 Molecular Test
Sorrento Stock Is Dashing Towards a Brighter Future, Says Analyst
Former FDA Commissioner Questions Hahn’s Covid-19 Vaccine Fast-Track Statement
FDA commissioner willing to fast-track Covid-19 vaccine: FT
Gilead’s Remdesivir Now Authorized For All Hospitalized Covid-19 Patients
Abbott Expanding Its Covid-19 Test To Asymptomatic People- Report
Abbott Scores $760M US Gov Deal For Rapid Covid-19 Saliva Test
Novavax: Despite Another Pullback, This Analyst Says 'Buy'
Trump administration to purchase 150 million Abbott Covid-19 tests
Thursday's Market Snapshot: Here's What You Need To Know Right Now
FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines
Thursday’s Pre-Market: Here’s What You Need To Know Before The Market Opens
Abbott Jumps 22% On Emergency Use Nod For Credit Card Size Covid-19 Test
Wednesday’s Pre-Market: Here’s What You Need To Know Before The Market Opens
Fluidigm’s Covid-19 Saliva Test Receives Emergency FDA Authorization
GOP Senators Demand FDA Explain Hydroxychloroquine Stance Amid Positive Studies And Physician Advocates
Qiagen To Roll Out Rapid Antibody Covid-19 Test In US As Citigroup Turns Bullish
US Close – Rally mode on vaccine/treatment optimism, Oil pares gains as storm weakens, Gold stumbles
I'm a lung doctor testing the blood plasma from COVID-19 survivors as a treatment for the sick – a century-old idea that could be a fast...
FDA issues an EUA for Convalescent Plasma to treat COVID
Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod
AstraZeneca Rises On Report Trump Could Fast-Track Covid-19 Vaccine Candidate
Futures Soars Above 3,400 To All Time High On Covid Plasma Treatment Approval
U.S. FDA authorizes use of blood plasma to treat coronavirus
Arcturus Inks Deal with Israel For Covid-19 Candidate; Analyst Sees 25% Upside
Gilead Says FDA Could Broaden Remdesivir Use Despite Data; Analyst Slashes PT
UPDATED: The leaders in the race to develop a Covid-19 vaccine say they could have pivotal data in October — but Trump claims FDA is slowing...
Gilead remdesivir study finds only marginal benefit for moderate Covid-19 patients
I'm a lung doctor testing the blood from COVID-19 survivors as a treatment for the sick – a century old idea that could be a fast...